Comparison of insulin autoantibody: Polyethylene glycol and micro-IAA 1-day and 7-day assays

Diabetes/Metabolism Research and Reviews

Volumn 25, Issue 7, 2009, Pages 665-670

  Babaya, Naru ^a   Liping, Yu ^a   Dongmei, Miao ^a   Jian, Wang ^a   Rewers, Marian ^a   Nakayama, Maki ^a   Liu, Edwin ^a   Barker, Jennifer M ^a   Eisenbarth, George S ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

CIAA; DAISY; Incubation time; mIAA; RIA; Type 1 diabetes

Indexed keywords

INSULIN; INSULIN ANTIBODY; MACROGOL;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; BLOOD DONOR; CONTROLLED STUDY; DIABETIC PATIENT; HUMAN; INCUBATION TIME; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN ANTIBODIES; MICROCHEMISTRY; MONITORING, IMMUNOLOGIC; POLYETHYLENE GLYCOLS; PREDIABETIC STATE; RADIOIMMUNOPRECIPITATION ASSAY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL PROTEIN A; TIME FACTORS;

EID: 70350582632     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.1014     Document Type: Article

References (18)

1. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998; 161: 3912-3918. (Pubitemid 28468965)
2. Robles DT, Eisenbarth GS, Dailey NJ, Peterson LB, Wicker LS. Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice. Diabetes 2003; 52: 882-886.
3. Barker JM, Barriga KJ, Yu L, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 2004; 89: 3896-3902. (Pubitemid 39071491)
4. Aly TA, Ide A, Humphrey K, et al. Genetic prediction of autoimmunity: Initial oligogenic prediction of anti-islet autoimmunity amongst DR3/DR4-DQ8 relatives of patients with type 1A diabetes. J Autoimmun 2005; 25(Suppl): 40-45. (Pubitemid 41728043)
5. Babaya N, Nakayama M, Eisenbarth GS. The stages of type 1A diabetes. Ann N Y Acad Sci 2005; 1051: 194-204.
6. Kurtz AB, Matthews JA, Mustaffa BE, Daggett PR, Nabarro JD. Decrease of antibodies to insulin, proinsulin and contaminating hormones after changing treatment from conventional beef to purified pork insulin. Diabetologia 1980; 18: 147-150.
7. Skyler JS, Krischer JP, Wolfsdorf J, et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial - Type 1. Diabetes Care 2005; 28: 1068-1076. (Pubitemid 40616615)
8. Williams AJ, Bingley PJ, Bonifacio E, Palmer JP, Gale EA. A novelmicro-assay for insulin autoantibodies. J Autoimmun 1997; 10: 473-478.
9. Yu L, Robles DT, Abiru N, et al. Early expression of anti-insulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci U S A 2000; 97: 1701-1706. (Pubitemid 30118506)
10. Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: first assay proficiency evaluation. Diabetes 2003; 52: 1128-1136. (Pubitemid 36523346)
11. Vardi P, Dib SA, Tuttleman M, et al. Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus. Diabetes 1987; 36: 1286-1291. (Pubitemid 17163989)
12. Nakayama M, Abiru N, Moriyama H, et al. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005; 435: 220-223. (Pubitemid 40685949)
13. Kent SC, Chen Y, Bregoli L, et al. Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope. Nature 2005; 435: 224-228. (Pubitemid 40685950)
14. Verge CF, Gianani R, Kawasaki E, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-933. (Pubitemid 26225509)
15. Verge CF, Stenger D, Bonifacio E, et al. Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. Diabetes 1998; 47: 1857-1866. (Pubitemid 28549191)
16. Franke B, Galloway TS, Wilkin TJ. Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies. Diabetes Metab Res Rev 2005; 21: 395-415. (Pubitemid 41320652)
17. Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114: 589-597. (Pubitemid 39572109)
18. Castano L, Ziegler AG, Ziegler R, Shoelson S, Eisenbarth GS. Characterization of insulin autoantibodies in relatives of patients with type I diabetes. Diabetes 1993; 42: 1202-1209. (Pubitemid 23219940)